Inaktiver Wert

Andere Sprachen Motif Bio plc Nasdaq

Aktien

MOTF BIO : BiVictriX Debuts on London's AIM Segment After $10 Million IPO	11.08.21
Motif Bio plc Announces Board Appointments	14.06.21
BiVictriX Therapeutics Ltd. cancelled the acquisition of Motif Bio plc in a reverse merger transaction.	14.06.21
Motif Bio plc Reports Earnings Results for the Full Year Ended December 31, 2020	10.05.21
Motif Bio : 2020 Annual Report and Accounts	10.05.21
Motif Bio plc Announces Board Changes	10.05.21
Orange Avenue Technologies LLC entered into a Stock Purchase Agreement to acquire Motif BioSciences, Inc. from Motif Bio plc	26.02.21
Motif Bio : Signs Reverse Takeover of Antibody-Drug Conjugate Company	27.01.21
BiVictriX Therapeutics Ltd. entered into a sale and purchase agreement to acquire Motif Bio plc for £5.5 million in a reverse merger transaction.	27.01.21
Motif Bio plc Reports Earnings Results for the Half Year Ended June 30, 2020	12.10.20
Motif Bio : Results of AGM	30.09.20
Motif Bio : Notification of Interim Results	23.09.20
Motif Bio : Annual Report and Accounts & Notice of AGM	09.09.20
Motif Bio plc Reports Earnings Results for the Full Year Ended December 31, 2019	01.09.20
Motif Bio : Delay in publication of Final Results	22.06.20
Motif Bio plc Announces Delay in Publication of Final Results for the Year Ended 31 December 2019	22.06.20
Motif Bio : Business Update and Appointment of Strategic Adviser	02.06.20
Motif Bio Appoints Adviser for Reverse Takeover Candidate	01.06.20
Motif Bio : Exercise of Warrants	18.05.20
Motif Bio : Placing to raise GBP650,000	06.05.20

Keine Ergebnisse zu dieser Suche